Last year, The European Union Agency for Cybersecurity (ENISA) launched the European Union’s Vulnerability Database (EUVD), which marked a pivotal moment in the evolution of global cybersecurity. For ...

The RCP’s Future Healthcare Journal (FHJ) has been officially accepted for indexation in Scopus, the world’s largest and most reputable abstract and citation database, recognising the quality and ...

The image shows a representation of the two main innovations of the new Google Maps. Credit: Google. Google Maps is ...

Though new regulatory frameworks address fairness, accountability, and safety in AI systems, they often fail to directly mitigate the subtle communication bias in LLMs that can distort public ...

At the end of January 2026, AstraZeneca, a Swedish-British pharmaceutical and biotechnology company, announced its re-entry into China's pharmaceutical market with a $15 billion investment over the ...

In Nigeria's federal health system, the question of who pays for healthcare is just as important as who delivers it. While national policies often dominate discussions on health sector reform, many of ...

A persistent tension exists between the drive for rapid technological advancement, the mandate for government oversight, and the paramount importance of patient safety. This dynamic which scrutinized ...

Learn how to implement cryptographic agility in Model Context Protocol (MCP) to protect AI infrastructure against quantum threats with PQC and modular security.

Thousands of women across Madhya Pradesh are waiting for the next installment of financial assistance under the Ladli Behna Yojana, one of the state government’s key welfare schemes. The upcoming 34th ...

The Citizens Life Sciences Conference 2026 March 10, 2026 4:00 PM EDTCompany ParticipantsMark Jacobson - Chief ...

As soon as online photo storage startup SmugMug Inc. heard about Amazon.com Inc.’s Simple Storage Service, an online data storage repository that debuted on March 14, 2006, “my eyes got all big,” ...

Acurx Pharmaceuticals, Inc. (NASDAQ: ACXP) (“Acurx” or the “Company”), a late-stage biopharmaceutical company developing a new class of antibiotics for difficult-to-treat bacterial infections, ...